Acuta Capital Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Acuta Capital Partners’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-92,000	Closed	-$1.63M	–	34
2018 Q3	$1.63M	Buy	+92,000	New	+$1.58M	0.58%	25

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Acuta Capital Partners's ECYT Position: Q4 2018 in Review

Acuta Capital Partners sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 92,000 shares — an estimated $1.63M sold.

Acuta Capital Partners first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $1.63M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Acuta Capital Partners reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Acuta Capital Partners sold 92,000 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.63M.
Acuta Capital Partners first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Acuta Capital Partners's Endocyte, Inc. Common Stock position peaked at $1.63M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Acuta Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.